Perioperative medicine & outcomes

Effects of ketamine on postoperative cognition: a scoping review

Br J AnaesthPublished Scoping review

Study context

Population
Adult surgical patients
Participants
6,830 patients · 58 studies
Exposure
Ketamine ketamine, esketamine or arketamine) before or during GA
Outcome
Cognitive benefit of ketamine
Methodological detailssystematic search of Embase and Embase Classic (1947–2025), clinical trials and retrospective cohort analyses, Most trials underpowered for cognitive endpoints; populations and methods too heterogeneous for meta-analysis
  • Systematic search of Embase and Embase Classic (1947–2025)
  • Clinical trials and retrospective cohort analyses
  • Most trials underpowered for cognitive endpoints; populations and methods too heterogeneous for meta-analysis

Main finding

As reported in the abstract

No cognitive benefits

35 of the 58 studies

60%

Reduced incidence or duration of perioperative neurocognitive disorders, or both

23 studies

40%

Observational data: associations, not effects.

Further findings

Dose, enantiomeric formulation, timing of administration

No clear trends associated with favourable cognitive outcomes

Timing of cognitive assessment

Studies assessing cognition only at early postoperative timepoints more likely to report no benefit

Outcomes and tools assessed

Studies evaluating postoperative delirium
31
Delirium studies using a Confusion Assessment Method derivative
81%
Studies evaluating other perioperative neurocognitive disorders
39
Of these, using Mini Mental State Examination
24 (62%)
Of these, using Montreal Cognitive Assessment
six (15%)

Original publication

Effects of ketamine on postoperative cognition: a scoping review. Br J Anaesth. Published 7 July 2025. doi:10.1016/j.bja.2025.05.035

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.